GRACE: A Phase 1/2a Study of VTRU200 in Relapsed/Refractory AML, High-risk MDS, DLBCL Post CART Failure and Advanced Solid Tumors

NCT07749976 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia
Diffuse Large B Cell Lymphoma (DLBCL)
High Risk Myelodysplastic Syndrome
Solid Tumor Malignancies
Pediatric Acute Myeloid Leukemia

Interventions

BIOLOGICAL: VTRU200

Sponsor

Vitruviae